Patents
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
04/1997
04/10/1997WO1997012870A1 Tetrahydroquinolines as nmda antagonists
04/10/1997CA2232509A1 Tetrahydroquinolines as nmda antagonists
04/09/1997EP0766668A1 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof
04/09/1997EP0568574B1 Method of preparation of a pyrogen-free fructane which is readily soluble in water, and an agent containing such a fructane for the examination of kidney function
04/08/1997US5618925 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
04/08/1997US5618805 19-nor-vitamin D compounds
04/08/1997US5618542 Vaccines comprising antigenic polypeptides of Taenia ovis
04/08/1997US5618537 Plant-based medicaments for increasing the tone and modulating the tone of the smooth muscular organ
04/08/1997US5618518 Methods and compositions for use against dental calculus in domestic animals
04/03/1997WO1997011675A1 Stable aqueous abrasive peroxide tooth whitening dentifrice
04/03/1997CA2233006A1 Stable aqueous abrasive peroxide tooth whitening dentifrice
04/02/1997EP0765665A1 Use of dideoxy nucleoside analogues in the treatment of viral infections
04/02/1997EP0765308A1 Enzyme inhibitors
04/02/1997EP0765167A1 Suppression of tumor cell growth by syndecan-1 ectodomain
04/02/1997EP0576456B1 Pharmaceutical compositions for the treatment of skin disorders
04/01/1997US5616587 Aqueous risperidone formulations
04/01/1997US5616483 Genomic DNA sequences encoding human BSSL/CEL
03/1997
03/27/1997WO1997010804A1 Body wash composition to impart conditioning properties to skin
03/27/1997WO1997004788A3 Use of calendula glycosides for the treatment of psoriasis
03/27/1997WO1997002051A3 Cascade polymer complexes
03/27/1997WO1996039153A3 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis
03/26/1997EP0764174A1 Process for removing bile salts from a patient and alkylated compositions therefor
03/25/1997US5614625 Collagenase inhibitors
03/25/1997US5614180 Shampoo-conditioner composition
03/25/1997US5614168 Multinuclear complexes for X-ray imaging
03/25/1997CA2067178C Solid tumor treatment method and composition
03/25/1997CA2050479C Cd3 specific recombinant antibody
03/25/1997CA1339022C Lactam derivatives
03/19/1997EP0763541A1 11-(Substituted phenyl)-estra-4,9-diene derivatives
03/19/1997EP0763114A2 Hepatitis g virus and molecular cloning thereof
03/19/1997EP0762888A1 Copolymer-1 improvements in compositions of copolymers
03/19/1997EP0762883A1 Pyridylbisphosphonates for use as a therapeutical agent
03/19/1997EP0762876A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof
03/19/1997EP0762867A1 Skin and hair care product
03/19/1997EP0600934B1 Oligosaccharides of dermatan sulphate, process for their production, and associated pharmaceutical compositions
03/19/1997EP0445135B1 Immogenically active fractions of borrelia burgdorferi
03/19/1997CN1145168A In ovo vaccination against coccidiosis
03/18/1997US5612349 Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms
03/18/1997US5612307 Cleansing and moisturizing skin
03/18/1997CA2087600C Antineoplastic chemotherapeutic of plant origin, having high selectivity and greatly reduced toxicity, and process for the preparation thereof
03/13/1997WO1997009033A1 Hand cleanser
03/12/1997EP0761215A1 Antibacterial agent
03/12/1997EP0761211A1 Sustained release composition
03/12/1997EP0761208A1 Process for preparing dry pharmaceutical forms and compositions thus made
03/12/1997EP0760646A1 Combined two-part reducing agent/humectant shaving system for improved shaving comfort
03/11/1997US5609859 Lithium carbonate, sulfate or phosphate and alkaline earth metal hydroxide, reduced irritation, less destruction to hair
03/11/1997US5609854 Sunscreen
03/11/1997US5609853 Photoprotective/cosmetic compositions comprising synergistic admixture of sunscreen compounds
03/11/1997CA2109435C Compositions of n-(phosphonoacetyl)-l-aspartic acid and methods of their use as broad spectrum antivirals
03/06/1997WO1997008321A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/06/1997WO1997008144A1 Substituted benzylaminopiperidine compounds
03/06/1997WO1997007775A1 Improved hair straightening emulsion
03/06/1997CA2666298A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/05/1997EP0759765A1 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
03/05/1997CN1144217A Retinoid-like compounds
03/04/1997US5607956 1-heteroazolyl-1-heterocyclyl alkane derivatives and their use and their use as neuroprotective agents
03/04/1997US5607662 Pharmaceutical inhalation compositions
03/04/1997CA2166794C Magnesium omeprazole
03/04/1997CA1338957C Avirulent microbes and uses therefor
02/1997
02/27/1997WO1997006822A1 Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage
02/27/1997WO1997006778A1 Cosmetic gel composition having reduced skin irritation
02/27/1997CA2229787A1 Cosmetic gel composition having reduced skin irritation
02/27/1997CA2229140A1 Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage
02/26/1997EP0759297A1 Remedy for pulmonary heart
02/26/1997EP0758963A1 Positioning device for a mobile phone
02/26/1997EP0758879A1 Improved anti-dandruff shampoo
02/26/1997EP0625905A4 Composition containing body activated fragrance for contacting the skin and method of use.
02/26/1997CN1143965A Carbocyclic compound
02/25/1997US5606108 Process for preparing anionic polycarbonate and polyester oligomers having useful antiviral properties
02/25/1997US5605930 Compositions and methods for treating and preventing pathologies including cancer
02/25/1997US5605682 Composition consisting of particles of antiperspirant alone or in combination with filler, suspending agent, liquid emollient carrier, propellant
02/25/1997US5605680 Photostable cosmetic composition containing a UV-A screen and a UV-B screen and a process for stabilizing the UV-A screen with the UV-B screen
02/25/1997US5605679 Topically applicable sunscreen containing 4-methylbenzylidenecamphor dissolved in 2-ethylhexyl alpha-cyano-beta,beta-diphenylacrylate solvent in cosmetically acceptable vehicle, diluent or carrier
02/25/1997CA2079680C Hair styling shampoos
02/20/1997WO1996039147A3 Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases
02/19/1997EP0758244A1 Controlled-release dosage forms of azithromycin
02/19/1997CN1034077C Preparation of new pyrido|2,3-f¨|1,4¨ thiazepines
02/19/1997CN1034055C Monoclone antibody used for preparing medicine of therapeutic imflammation region
02/19/1997CN1034054C Preparing method for improved oligosaccharide conjugate vaccines
02/18/1997US5604223 Treating epilepsy, nervous system disorder
02/18/1997US5603925 Containing polyamide gelation agent
02/13/1997WO1997004788A2 Use of calendula glycosides for the treatment of psoriasis
02/13/1997WO1997004749A1 Method for preparing dry pharmaceutical forms, and resulting pharmaceutical compositions
02/13/1997CA2227751A1 Use of calendula glycosides for the treatment of psoriasis
02/12/1997EP0757991A1 Bioavailable crystalline form of cefuroxime axetil
02/12/1997CN1142499A Tricyclic 5,6-dihydro-9H-pyrazolo|3,4-c¨-1,2,4,-triaolo (4,3-alpha¨ pyridines
02/11/1997US5602112 Pharmaceutical formulation
02/11/1997US5601837 Oral pharmaceutical composition comprising small particle size psyllium husk, cholestyramine resin
02/11/1997US5601831 Vaccines for nontypable Haemophilus influenzae
02/05/1997EP0756868A2 Aerosol compositions
02/05/1997EP0756602A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
02/05/1997EP0756595A1 Substituted 1,3-oxathiolanes with antiviral properties
02/05/1997CN1142186A Use of IL-10 to stimulate peripheral blood mononuclear cell cytolytic activity
02/05/1997CN1142181A Oral compsition
02/04/1997US5599692 Antigenic polypeptides of Taenia ovis
02/04/1997US5599525 Having first component containing calcium peroxide and free of reactive ingredient, second component containing sodium bicarbonate and reactive colorant; storage stability
02/04/1997CA2179359A1 Bioavailable crystalline form of cefuroxime azetil
01/1997
01/30/1997WO1997003084A1 New inhibitors of platelet aggregation
01/30/1997CA2226758A1 New inhibitors of platelet aggregation
01/29/1997EP0755682A1 Methods of treatment of motor neuron diseases using members of the BDNF/NT-3/NGF family of molecules